Logo image of TLIK.DE

ARZNEIWERK AG VIDA (TLIK.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:TLIK - DE000A289B07 - Common Stock

0.585 EUR
+0.08 (+17%)
Last: 6/27/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to TLIK. TLIK was compared to 28 industry peers in the Health Care Providers & Services industry. TLIK has a bad profitability rating. Also its financial health evaluation is rather negative. TLIK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TLIK had negative earnings in the past year.
In the past year TLIK has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: TLIK reported negative net income in multiple years.
In multiple years TLIK reported negative operating cash flow during the last 5 years.
TLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFTLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

TLIK has a worse Return On Assets (-18.11%) than 92.00% of its industry peers.
Industry RankSector Rank
ROA -18.11%
ROE N/A
ROIC N/A
ROA(3y)-50.09%
ROA(5y)11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLIK.DE Yearly ROA, ROE, ROICTLIK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

Looking at the Gross Margin, with a value of 6.17%, TLIK is doing worse than 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of TLIK has declined.
The Profit Margin and Operating Margin are not available for TLIK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-59.12%
GM growth 5Y-38.57%
TLIK.DE Yearly Profit, Operating, Gross MarginsTLIK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

0

2. Health

2.1 Basic Checks

TLIK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLIK remains at a similar level compared to 1 year ago.
TLIK has a worse debt/assets ratio than last year.
TLIK.DE Yearly Shares OutstandingTLIK.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
TLIK.DE Yearly Total Debt VS Total AssetsTLIK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that TLIK is in the distress zone and has some risk of bankruptcy.
TLIK has a Altman-Z score (1.19) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACC4.48%
TLIK.DE Yearly LT Debt VS Equity VS FCFTLIK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

TLIK has a Current Ratio of 0.63. This is a bad value and indicates that TLIK is not financially healthy enough and could expect problems in meeting its short term obligations.
TLIK has a Current ratio of 0.63. This is in the lower half of the industry: TLIK underperforms 72.00% of its industry peers.
TLIK has a Quick Ratio of 0.63. This is a bad value and indicates that TLIK is not financially healthy enough and could expect problems in meeting its short term obligations.
TLIK has a Quick ratio of 0.26. This is amonst the worse of the industry: TLIK underperforms 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.26
TLIK.DE Yearly Current Assets VS Current LiabilitesTLIK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.64% over the past year.
The Revenue for TLIK has decreased by -19.21% in the past year. This is quite bad
TLIK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 62.08% yearly.
EPS 1Y (TTM)82.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.14%
Revenue 1Y (TTM)-19.21%
Revenue growth 3Y176.64%
Revenue growth 5Y62.08%
Sales Q2Q%-0.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLIK.DE Yearly Revenue VS EstimatesTLIK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TLIK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLIK.DE Price Earnings VS Forward Price EarningsTLIK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLIK.DE Per share dataTLIK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TLIK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARZNEIWERK AG VIDA

FRA:TLIK (6/27/2025, 7:00:00 PM)

0.585

+0.08 (+17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-26 2025-05-26
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners34.31%
Ins Owner ChangeN/A
Market Cap3.64M
Revenue(TTM)59.68M
Net Income(TTM)-2.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS9.58
BVpS-0.8
TBVpS-0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.17%
FCFM N/A
ROA(3y)-50.09%
ROA(5y)11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-59.12%
GM growth 5Y-38.57%
F-Score2
Asset Turnover4.91
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.65%
Cap/Sales 0.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.26
Altman-Z 1.19
F-Score2
WACC4.48%
ROIC/WACCN/A
Cap/Depr(3y)64.75%
Cap/Depr(5y)48.85%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.21%
Revenue growth 3Y176.64%
Revenue growth 5Y62.08%
Sales Q2Q%-0.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.91%
OCF growth 3YN/A
OCF growth 5YN/A

ARZNEIWERK AG VIDA / TLIK.DE FAQ

Can you provide the ChartMill fundamental rating for ARZNEIWERK AG VIDA?

ChartMill assigns a fundamental rating of 1 / 10 to TLIK.DE.


What is the valuation status for TLIK stock?

ChartMill assigns a valuation rating of 0 / 10 to ARZNEIWERK AG VIDA (TLIK.DE). This can be considered as Overvalued.


What is the profitability of TLIK stock?

ARZNEIWERK AG VIDA (TLIK.DE) has a profitability rating of 1 / 10.